免責事項: 本サイトは、FDA、ClinicalTrials.gov、PubMed、SEC EDGAR などの公式公開データを一般参考用に集約するものであり、医学的助言、診断、治療推奨、投資助言を構成しません。

PubMed

Ethical concerns regarding a lack of standardized clinical demographic data: an audit of 2023 FDA medical devices.

PMID: 42095631 ·

E, m, m, a, , W, h, i, t, e, h, o, u, s, e, ;, , M, a, r, i, a, n, n, e, , S, w, a, i, n, ;, , W, e, s, l, e, y, , S, h, u, m, a, r

学術誌Expert review of medical devices
年
PMID42095631

抄録

Medical devices have been regulated by the Food and Drug Administration since 28 May 1976. The FDA does not currently require that medical device companies publish diversity data across all device approval pathways. Demographic information is imperative because it enables stakeholders to note the safety of medical devices with different demographic groups. The aim of this article is to quantify the demographic information publicly available on the FDA's 2023 Device Approvals page. The N = 52 med

公式ソース

PubMedで見る →

データはPubMed / NCBIから取得しています。全文および最新情報は必ず公式記録をご確認ください。

↑